Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial-Reference-Cited by-同舟云学术

Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial

Published:2021-01-31 Issue:2 Volume:14 Page:261-268
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Mennitto A.¹^ORCID,Verzoni E.¹^ORCID,Cognetti F.²,Miceli R.³^ORCID,Milella M.⁴,Mosca A.⁵^ORCID,Chiuri V. E.⁶,Bearz A.⁷,Morelli F.⁸^ORCID,Ortega C.⁹,Atzori F.¹⁰^ORCID,Donini M.¹¹,Claps M.¹^ORCID,Guadalupi V.¹^ORCID,Sepe P.¹,Cappelletti V.¹²^ORCID,de Braud F. G.¹¹³^ORCID,Procopio G.¹^ORCID

Affiliation:

1. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy

3. Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

4. Department of Medicine, Medical Oncology, University and Hospital Trust of Verona, Verona, Italy

5. Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy

6. Medical Oncology Department, Ospedale Vito Fazzi, Lecce, Italy

7. Medical Oncology Department, National Cancer Institute, Aviano, Italy

8. Medical Oncology Department, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

9. Department of Medical Oncology, Ospedale S. Lazzaro ASL CN2 Alba-Bra, Cuneo, Italy

10. Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, Italy

11. Medical Oncology Department, Ospedale di Cremona, Cremona, Italy

12. Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy

13. Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1879639

Reference27 articles.

1. Multimodal treatment of advanced renal cancer in 2017

2. Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

3. Treatment of Advanced Renal Cell Carcinoma: Recent Advances and Current Role of Immunotherapy, Surgery, and Cryotherapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis;Journal of Urologic Oncology;2024-03-31

2. A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma;BMC Urology;2024-03-07

3. Meta-analysis of perioperative immunotherapy in renal cell carcinoma: Available, but the jury is still out;Urologic Oncology: Seminars and Original Investigations;2023-09

4. Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario;Cancer Treatment Reviews;2023-04

5. Role of adjuvant systemic therapy in high-risk renal cell carcinoma;Die Onkologie;2023-01-31